Syros Pharmaceuticals Inc (SYRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 69,575 | 92,302 | 115,420 | 160,915 | 222,142 |
| Marketable Securities | 40,686 | 38,067 | 30,164 | 21,114 | N/A |
| Other current assets | 3,182 | 2,979 | 3,632 | 2,177 | 2,622 |
| TOTAL | $116,477 | $136,585 | $153,271 | $186,207 | $226,677 |
| Non-Current Assets | |||||
| PPE Net | 12,554 | 12,844 | 13,458 | 13,784 | 13,927 |
| Investments And Advances | 2,638 | 13,038 | 21,117 | 13,264 | 0 |
| Other Non-Current Assets | 20,412 | 20,468 | 20,197 | 20,479 | 20,023 |
| TOTAL | $35,604 | $46,350 | $54,772 | $47,527 | $33,950 |
| Total Assets | $152,081 | $182,935 | $208,043 | $233,734 | $260,627 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,667 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 2,841 | 3,692 | 4,108 | 3,671 | 3,660 |
| Accrued Expenses | 13,249 | 15,624 | 11,839 | 9,963 | 9,127 |
| TOTAL | $27,593 | $31,508 | $29,880 | $27,623 | $27,369 |
| Non-Current Liabilities | |||||
| Long Term Debt | 38,775 | 40,257 | 40,072 | 39,892 | 39,718 |
| Deferred Revenues | 7,773 | 10,181 | 11,995 | 12,123 | 12,786 |
| Other Non-Current Liabilities | 22,959 | 25,887 | 28,911 | 31,177 | 36,208 |
| TOTAL | $61,746 | $66,209 | $72,103 | $76,134 | $83,378 |
| Total Liabilities | $89,339 | $97,717 | $101,983 | $103,757 | $110,747 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 6,282 | 6,208 | 6,195 | 6,193 | 6,186 |
| Common Shares | 61 | 6 | 61 | 61 | 61 |
| Retained earnings | -488,725 | -463,579 | -439,766 | -413,739 | -391,249 |
| Other shareholders' equity | -273 | -79 | -5 | -19 | 0 |
| TOTAL | $62,742 | $85,218 | $106,060 | $129,977 | $149,880 |
| Total Liabilities And Equity | $152,081 | $182,935 | $208,043 | $233,734 | $260,627 |